Opioid Withdrawal
35
6
7
20
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
5.7%
2 terminated out of 35 trials
90.9%
+4.4% vs benchmark
14%
5 trials in Phase 3/4
50%
10 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (35)
Evaluating Buspirone to Treat Opioid Withdrawal
Tapering From Long-term Opioid Therapy in Chronic Pain Population. Randomized Controlled Trial With 12 Months Follow up
Sublingual Dexmedetomidine for Treating Opioid Withdrawal
Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder
CEDRN: Opioid Registry
An Innovative Intervention for OUD Treatment
Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder
ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain
Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD
Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder
Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain
Suboxone Dispenser for OUD
Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal
Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions
Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal
Oral Cannabidiol for Opioid Withdrawal
Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing
Opioid Tapering After Spine Surgery
Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER)